NeOnc Technologies Holdings, Inc. Common Stock (NTHI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NeOnc Technologies Holdings, Inc. Common Stock (NTHI) has a cash flow conversion efficiency ratio of 0.257x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.77 Million) by net assets ($-18.53 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is NeOnc Technologies Holdings, Inc. Common worth for the company's overall valuation and market capitalisation.
NeOnc Technologies Holdings, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how NeOnc Technologies Holdings, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NeOnc Technologies Holdings, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NeOnc Technologies Holdings, Inc. Common Stock ranked by their cash flow conversion efficiency. See NTHI operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Prozone Realty Limited
NSE:PROZONER
|
0.044x |
|
Anixa Biosciences Inc
NASDAQ:ANIX
|
-0.132x |
|
Atlas Lithium Corporation Common Stock
NASDAQ:ATLX
|
-0.202x |
|
Beauty Health Co
NASDAQ:SKIN
|
0.048x |
|
Torque Metals Ltd
AU:TOR
|
-0.008x |
|
La Kaffa International Co Ltd
TWO:2732
|
0.098x |
|
Arq Inc
NASDAQ:ARQ
|
0.001x |
|
Young Bag Micro Motors Co Ltd
KQ:193250
|
-0.038x |
Annual Cash Flow Conversion Efficiency for NeOnc Technologies Holdings, Inc. Common Stock (2021–2025)
The table below shows the annual cash flow conversion efficiency of NeOnc Technologies Holdings, Inc. Common Stock from 2021 to 2025. View NeOnc Technologies Holdings, Inc. Common stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-17.51 Million | $-20.36 Million | 1.163x | +51.95% |
| 2024-12-31 | $-5.50 Million | $-4.21 Million | 0.765x | +469.55% |
| 2023-12-31 | $-13.99 Million | $-1.88 Million | 0.134x | -75.99% |
| 2022-12-31 | $-1.58 Million | $-881.74K | 0.560x | +269.14% |
| 2021-12-31 | $-2.62 Million | $-396.69K | 0.152x | -- |
About NeOnc Technologies Holdings, Inc. Common Stock
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical… Read more